EGFR and lung adenocarcinoma: Before the emergence of radiomics, the clinical characteristics of patients with lung adenocarcinoma were frequently applied to predict EGFR mutation status, and multiple clinical characteristics (e.g., female, non-smoker, and adenocarcinoma histology) were related to EGFR mutations (32).